$1.99 (1.02%)

Volume: 54.798k

Closed: Jun 02, 2023

Hollow Logo Score: -0.088
Cellectis S.A. Stock
$1.99 (1.02%)

Volume: 54.798k

Closed: Jun 02, 2023

Score Hollow Logo -0.088
NASDAQ:CLLS

Cellectis S.A. Stock Price (Quote)

$1.99 ( 1.02% ) Friday, 2nd Jun 2023

Range Low Price High Price Comment
30 days $1.68 $2.00 Friday, 2nd Jun 2023 CLLS stock ended at $1.99. This is 1.02% more than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 3.09% from a day low at $1.94 to a day high of $2.00.
90 days $1.68 $2.23
52 weeks $1.68 $4.10

Historical Cellectis S.A. prices

Date Open High Low Close Volume
2023-06-02 $1.99 $2.00 $1.94 $1.99 54 798
2023-06-01 $1.94 $1.99 $1.89 $1.97 39 883
2023-05-31 $1.91 $1.91 $1.85 $1.90 58 216
2023-05-30 $1.80 $1.90 $1.80 $1.90 63 440
2023-05-26 $1.82 $1.88 $1.80 $1.83 17 068
2023-05-25 $1.81 $1.83 $1.75 $1.78 34 118
2023-05-24 $1.81 $1.81 $1.71 $1.72 45 323
2023-05-23 $1.79 $1.83 $1.78 $1.80 24 092
2023-05-22 $1.74 $1.80 $1.71 $1.80 31 805
2023-05-19 $1.75 $1.77 $1.70 $1.74 19 008
2023-05-18 $1.77 $1.79 $1.71 $1.77 64 907
2023-05-17 $1.75 $1.82 $1.75 $1.80 49 180
2023-05-16 $1.70 $1.82 $1.69 $1.75 65 528
2023-05-15 $1.75 $1.81 $1.73 $1.76 51 242
2023-05-12 $1.81 $1.82 $1.68 $1.74 207 426
2023-05-11 $1.90 $1.92 $1.81 $1.81 161 059
2023-05-10 $1.84 $1.92 $1.84 $1.92 35 452
2023-05-09 $1.81 $1.85 $1.78 $1.83 56 784
2023-05-08 $1.95 $1.95 $1.82 $1.90 166 033
2023-05-05 $1.89 $1.98 $1.89 $1.90 162 929
2023-05-04 $1.92 $1.92 $1.86 $1.88 53 003
2023-05-03 $1.90 $1.94 $1.86 $1.86 48 948
2023-05-02 $1.91 $1.92 $1.80 $1.83 33 800
2023-05-01 $1.95 $1.96 $1.93 $1.95 11 698
2023-04-28 $1.88 $1.92 $1.88 $1.88 28 475
2023-04-27 $1.93 $1.95 $1.90 $1.94 3 350
2023-04-26 $1.93 $1.93 $1.90 $1.91 7 396
2023-04-25 $1.90 $1.94 $1.89 $1.94 12 961
2023-04-24 $1.89 $1.94 $1.89 $1.93 27 193
2023-04-21 $1.99 $1.99 $1.88 $1.90 113 358
2023-04-20 $1.97 $1.99 $1.92 $1.92 45 738
2023-04-19 $1.99 $2.03 $1.93 $2.03 43 942
2023-04-18 $2.04 $2.04 $1.97 $2.01 134 020
2023-04-17 $2.04 $2.07 $2.01 $2.04 70 360
2023-04-14 $2.08 $2.14 $2.04 $2.04 46 427
2023-04-13 $2.04 $2.17 $2.04 $2.12 177 718
2023-04-12 $1.99 $2.05 $1.99 $2.05 50 324
2023-04-11 $1.96 $2.00 $1.94 $1.98 32 051
2023-04-10 $1.99 $1.99 $1.91 $1.96 14 573
2023-04-06 $1.99 $1.99 $1.90 $1.97 44 698
2023-04-05 $1.92 $1.99 $1.91 $1.98 18 051
2023-04-04 $2.00 $2.02 $1.93 $1.97 23 313
2023-04-03 $1.96 $2.02 $1.96 $2.01 32 553
2023-03-31 $1.98 $2.03 $1.90 $1.93 91 773
2023-03-30 $2.01 $2.05 $1.96 $2.02 203 462
2023-03-29 $2.07 $2.09 $1.85 $1.91 435 640
2023-03-28 $2.04 $2.06 $2.02 $2.04 6 651
2023-03-27 $2.03 $2.08 $1.97 $1.99 112 721
2023-03-24 $2.02 $2.09 $1.98 $2.04 50 253
2023-03-23 $2.07 $2.11 $1.96 $2.04 23 346
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT